Bioreactors Market Size by Product Type (Single-use, Reusable), By Cell (Mammalian Cells, Bacterial Cells, Yeast Cells), By Molecule (Monoclonal Antibodies, Vaccines, Recombinant Proteins, Stem Cells, Gene Therapy), By End-use (R&D Organizations, Biopharma Manufacturers, CMOs), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2020 – 2026

Published Date: Sep 2020  |  Report ID: GMI141  |  Authors: Sumant Ugalmugle, Rupali Swain

Report Format: PDF   |   Pages: 150   |   Base Year: 2019

Summary Table of Contents Industry Coverage Methodology

Industry trends

Bioreactors Market size valued at over USD 4 billion in 2019 and is expected to witness 16.1% CAGR from 2020 to 2026. Growing demand for vaccines, monoclonal antibodies and development of several other biotechnological products will boost the market revenue.

Bioreactors Market
Get more details on this report - Request Free Sample PDF

With recent outbreak of COVID-19 globally, the demand for bioreactors has escalated substantially for the development of vaccines and therapeutics for better medical treatment. Moreover, rising demand for technological advanced products for better manufacturing and production will further drive the adoption of bioreactors in the healthcare industry.

According to the World Health Organization (WHO), millions of people have been affected by COVID-19 resulting into high mortality rate. To reduce the mortality rate and for better medical outcomes, various major market players are working together for the development of effective vaccines. Thus, demand for bioreactors will upsurge to cater to increasing need of vaccine development. Government in various countries are also taking numerous initiatives to form global partnership with major market players for proper management of vaccine development. However, stringent regulatory landscape associated with manufacturing and marketing standards of bioreactors may limit product approvals of product manufacturers.

Bioreactors Market Report Coverage
Report Coverage Details
Base Year: 2019 Market Size in 2019: 4.4 Billion (USD)
Historical Data for: 2015 to 2019 Forecast Period: 2020 to 2026
Forecast Period 2020 to 2026 CAGR: 16.1% 2026 Value Projection: 12.5 Billion (USD)
Pages: 150 Tables, Charts & Figures: 233
Geographies covered (19): U.S., Canada, UK, France, Germany, Spain, Italy, The Netherlands, Denmark, China, India, Japan, Australia, Singapore, South Korea, Brazil, Mexico, South Africa, UAE
Segments covered: Product Type, Cell, Molecule, End-use
Companies covered (17): Thermo Fisher Scientific, PBS Biotech, GE Healthcare, Merck Group, Cellexus Ltd., Pall Corporation, Sartorius Stedim Biotech Group, Applikon Biotechnology, Inc., GEA Group Aktiengesellschaft, BioTron, Inc., Bbi Biotech, Shanghai Bailun Biotechnology Co., Ltd., CerCell Aps, Eppendorf AG, Solaris Biotech Solutions, Pierre Guérin, CESCO Bioengineering Co. Ltd.
Growth Drivers:
  • Rising biopharmaceuticals and biologics companies
  • Technological advancements in single-use bioreactors
  • Growing focus on orphan drugs development
  • Increasing demand for personalized medicines
Pitfalls & Challenges:
  • Low capacity of single-use bioreactors
  • Concerns regarding extractables and/or leachables

Get more details on this report - Request Free Sample PDF

Rising number chronic disorders worldwide will propel the usage of bioreactors to produce biologics

Growing incidence of various chronic disorders and other infectious diseases has increased the demand for better medical treatment options, driving the bioreactors market growth. The usage of bioreactors in pharmaceutical and biotechnology industry will witness surge. Bioreactors offer many advantages to vaccine development in terms of quality and quantity during mass production. The benefit offered includes cost reduction in manufacturing that is more affordable in emerging economies. Furthermore, various advantages such as flexibility, mass production and optimal culture conditions will further augment the market expansion.

Technological advances in reusable bioreactors will stimulate its adoption rate

Global Bioreactors Market

Get more details on this report - Request Free Sample PDF

Reusable bioreactors market dominated over 80% revenue share in 2019. Advantages such as flexibility, cost-efficiency and increased yield has offered substantial growth in the use of reusable bioreactors in biotechnology and pharmaceutical industry. Moreover, advancements in these bioreactors will spur its adoption rate over the coming years.

Growing use of mammalian cells in pharmaceutical industry for quality medical products

Mammalian cells segment will register growth rate of 16.2% during the forecast period. Rising prevalence of various disorders, increasing healthcare spending by government and major market players will increase the use of bioreactors for mammalian cells cultivation. Moreover, growing pharmaceutical and biotechnology industry and development of biologics will further fuel the segment growth.

Growing demand of advanced antibiotics and vaccines for better therapeutics will spur the bioreactors market demand in the healthcare industry. Owing to various advantages such as high cell density microbial cell cultivation, resistance to shear damage and increased production capacity will drive the segment growth.

Escalating demand of vaccines to reduce mortality rate due to chronic disorders will augment the use of bioreactors

Vaccines segment size in the bioreactor market was over USD 2 billion in 2019. Prevalence of infectious diseases has escalated the demand for vaccines in the recent years. Moreover, rising healthcare expenditure by the government and major market players into research and development will positively impact the market outlook.

Stem cells have great potential to treat various injuries, diseases, and other medical conditions.  With growing applications such as treatment of blood-related disorders, tissue grafting, bone or skin injury, the stem cell segment will observe lucrative growth in near future.

Rising research and development activities for vaccine and other biologics will poise the bioreactors market growth

R&D organizations segment accounted for over USD 2 billion revenue in 2019, owing to growing impact of sophisticated research infrastructure and skilled workforce. Research and development organizations are gaining better funding for developing novel therapies. This will impel adoption rate of bioreactors in research field in the future.

Biopharmaceutical manufacturers will also showcase significant growth between 2020 and 2026 due to expanding number biotechnology firms in emerging economies. In addition, rising focus on drug development will further stimulate the segment growth trends.

Rising healthcare expenditure and presence of major market players in North America

North America Bioreactors Market

Get more details on this report - Request Free Sample PDF

North America bioreactors market held substantial revenue share in 2019 and will expand at more than 15.5% CAGR through 2026. Regional growth is primarily attributed to presence of major market players constantly investing into research and development activities. In addition, increasing demand for newer drugs for treating rare diseases will boost the North American market value.

Increasing incidence of infectious diseases will favour the U.S. bioreactors industry size expansion. Moreover, various government initiatives and rising adoption technologically advanced products in the country will propel the U.S. market growth.

Key industry players are resorting to strategic partnerships that will enhance their business expansion

Some of the prominent players operating in the bioreactor market include Sartorius Stedim Biotech Group, Thermo Fisher Scientific, GE Healthcare, and Merck Group among other players. These market players are adopting various inorganic growth strategies to increase market share and obtain competitive advantage.

The bioreactors market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2015 to 2026 for the following segments:

Market, By Product Type

  • Single-use
  • Reusable

Market, By Cell

  • Mammalian Cells
  • Bacterial Cells
  • Yeast Cells
  • Others

Market, By Molecule

  • Monoclonal Antibodies
  • Vaccines
  • Recombinant Proteins
  • Stem Cells
  • Gene Therapy
  • Others

Market, By End-use

  • R&D Organizations
  • Biopharma Manufacturers
  • CMOs

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • The Netherlands
    • Denmark
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Singapore
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • South Africa
    • UAE


Frequently Asked Questions (FAQ) :

The market revenue for bioreactors was worth USD 4 billion in 2019. Driven by rising demand for monoclonal antibodies & vaccines, especially in the times of COVID-19, the industry size may register 16.1% CAGR through 2026.
Reusable products dominated a market share of 80% in 2019, due to their advantages such as cost-efficiency, increased yield, and flexibility.
Mammalian cells segment may record 16.2% CAGR through 2026 owing to surging prevalence of disorders and rising expenditure on healthcare by governments.
In 2019, the vaccines segment revenue crossed USD 2 billion. The prevalence of various infectious diseases will increase the segment outlook in the following years.
R&D organizations segment size was USD 2 billion in 2019. The segment will prove lucrative for industry growth due to rising impact of skilled workforce and R&D infrastructure.
North America market size may depict 15.5% CAGR through 2026 driven by the presence of numerous market players consistently investing in research and development activities.

Buy Now

Need a Discount? Get in touch with us for special pricing

Request Discount

Connect with our sales team

Premium Report Details

  • Published Date: Sep 2020
  • Pages: 150
  • Tables: 223
  • Charts / Figures: 10
  • Companies covered: 17
  • Countries covered: 19

Benefits of Association

Data Coverage & Quality

GMI reports provide the most comprehensive coverage of any focus industry, ensuring a holistic and deep understanding of the market, along with actionable and granular data. We also take pride in our commitment to quality and strive to ensure that our clients get their moneys worth.

Client Trust & Security

GMI maintains strict code of conduct as a business and is committed to ensure that the privacy and trust of our clients are always maintained. As an organization, we also strive to be fully compliant with privacy laws, PCI and information security guidelines.

Customer Service

Our customers rely on us to produce accurate, reliable and timely information. Service orientation is a key mission for us as an organization; our process is guided by the desire to ensure that our clients are provided the best possible solutions in optimal timeframe. GMI stands by its commitment to service, providing timely assistance in both pre-sales and post-sales support for our clients.

GMIPulse, our report store

We have introduced ‘GMIPulse’, which is our report store; designed to offer clients a one-stop platform for all market research and business intelligence requirements. Clients can access reports, presentations, raw data excel sheets as well as detailed company profiles. GMIPulse allows you to track relevant industries and stay informed with latest innovation, competitive and regulatory developments to help design strategic framework.

Chat with us
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. More info X